An atlas of genetic influences on human blood metabolites

Shin et al., Nature Genetics, 2014 [ Article | SI Text ]

Locus 139: SPTLC3 (20p12.1)

Meta-analysis summary statistics for associations meeting genome-wide significance
Lead SNPBiochemicalsEA/OANtotalEAFEffect (SE)PmetaDetails
rs4814176 X-10510 / palmitoyl sphingomyelin T/C 7343 0.4 0.021 (0.002) 7.49·10-33 show
rs4814176 X-08402 T/C 7284 0.39 0.022 (0.003) 2.97·10-17 show

EA = effect allele; OA = other allele; EAF = frequency of effect allele;

Summary of biological annotations
SNPrs4814176
Chromosomal locationChr20: 12,907,398 (20p12.1)
Gene (distance)SPTLC3 (-30,228)
Predicted causal geneSPTLC3
Gene/protein classification-
Metabolite (Pathway)X-10510 (Unknown)
palmitoyl sphingomyelin (Sphingolipid; Lipid)
Biochemical locus-metabolite relationshipSPTLC3 encodes a subunit of serine palmitoyltransferase [17023427]. SPT is the first step in de novo sphingolipid biosynthesis. Ratio interpretation: n/a.
eQTL associationsSPTLC3 (H) †

† F = adipose tissue; S = skin cells; L = lymphoblastoid cells; H = liver cells;

Medical information
Complex trait associations-
Known metabolite associationsSphingolipid levels [22359512,19798445]; SM (OH) C24:1/SM C16:0 [20037589]
Inborn error of metabolism-

Pharmacological information
ChEMBL ID-
Drug information -

Locus information for top associated metabolite

HapMap2 imputation

Imputation HapMap

1KGP imputation

Imputation 1KGP

 

Network view
Association map